Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study. - Hamer MJ; McCarty JM; Pierson BC; Regules JA; Mendy J; Sanborn AD; Gardner CL; Haller JM; Gregory MK; Liggett DL; Glass PJ; Ghosh N; et al. (The Lancet. Microbe, 2025)